CCRB Logo

Trial History Detail on 2011-02-08

CUHK_CCT00046

2005-09-08

Retrospective

Nil

Nil

n/a

n/a

Prof. Clement CY Tham

Dept. of Ophthalmology & Visual Sciences, Hong Kong Eye Hospital

2762 3196

clemtham@hkstar.com

The Chinese University of Hong Kong

Prof. Clement CY Tham

Dept. of Ophthalmology & Visual Sciences, Hong Kong Eye Hospital

2762 3196

clemtham@hkstar.com

The Chinese University of Hong Kong

Argon laser peripheral iridoplasty (ALPI) versus systemic intraocular pressure lowering medications as the immediate management for acute phacomorphic angle-closure (phacomorphic glaucoma).

Argon laser peripheral iridoplasty (ALPI) versus systemic intraocular pressure lowering medications as the immediate management for acute phacomorphic angle-closure (phacomorphic glaucoma).

Nil

Hong Kong

Yes

2005-07-13

Eye Diseases

Procedure

Argon laser peripheral iridoplasty

15 minutes

Drugs

Inclusion criteria Age: >18 years, able to give informed consent + co-operate during laser procedure First acute attack of phacomorphic angle closure Intraocular pressure >40 mmHg

Exclusion criteria Treatment received prior to study Corneal opacity preventing laser treatment to peripheral iris Uncooperative patients Single-eyed patients

n / a

n / a

Both Male and Female

Interventional

Randomized

Active

Open label

Parallel

2005-07-13

30

Complete

IOP

Return of corneal clarity Symptoms, particularly pain, nausea & vomiting, and visual acuity Corneal endothelial cell count by specular microscopy - serial Number and types of IOP lowering drugs required Evidence of optic nerve damage at presentation and follow-up Final visual outcome Final angle status by indentation gonioscopy Visual field loss Complications of treatment

No

2009-11-24

ChiCTR-TRC-09000645

2010-05-04


Yes

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.